Literature DB >> 30247970

Absent and Discordant Electronic Health Record Documentation of Complementary and Alternative Medicine in Cancer Care.

Daniela L Stan1, Dietlind L Wahner-Roedler1, Kathleen J Yost2, Thomas Jamie O'Byrne2, Megan E Branda2, Aaron L Leppin2, Jon C Tilburt1,3,4.   

Abstract

OBJECTIVES: Many patients with cancer use complementary and alternative medicine (CAM), but the quality of CAM documentation in their electronic health records (EHRs) is unknown. The authors aimed to describe (i) the prevalence and types of CAM used after cancer diagnosis and the influence of oncologists on CAM use, as per patients' self-report, and (ii) the prevalence of CAM documentation in the EHR and its consistency with self-reported usage.
DESIGN: Patient and provider surveys and chart review. SETTINGS/LOCATION: Medical oncology practices at one institution.
SUBJECTS: Patients with cancer at oncologist visits. OUTCOME MEASURES: Patient self-reported rate of 3-month postvisit CAM use; provider EHR documentation of CAM use or discussion and its concordance with patient self-report.
RESULTS: Among 327 patients enrolled, 248 responded to the 3-month postvisit survey. Of these, 158 reported CAM use after diagnosis (63.7%). CAM users were younger (p < 0.001) and had a higher percentage of women (p = 0.03) than nonusers. Modalities most commonly used were supplements (62.6%), special diets (38.6%), chiropractor (28.4%), and massage (28.4%). CAM was used to improve well-being (68.7%), manage adverse effects (35.5%), and fight cancer (22.9%). Oncologists suggested CAM in 22.5% of instances of use. CAM use/discussion was documented for 58.2% of self-reported CAM users. Of the documented modalities, EHR and self-report were concordant for only 8.2%. CAM documentation was associated with physician provider (p = 0.03), older patients (p = 0.01), and treatment with radiation (p = 0.03) or surgery (p = 0.001). After adjusting for other factors, patients with breast cancer or "other" tumor category were four times more likely than patients with gastrointestinal cancer to have CAM use documentation (odds ratio [95% confidence interval]: 4.41 [1.48-13.10]; 3.76 [1.42-9.99], respectively).
CONCLUSIONS: Most patients with cancer use CAM after diagnosis, yet EHR documentation is complete for very few. Oncologists should inquire about, document, and discuss CAM benefits and harm or refer patients to CAM specialists.

Entities:  

Keywords:  CAM; EHR; complementary and alternative medicine; oncology

Mesh:

Year:  2018        PMID: 30247970      PMCID: PMC6157347          DOI: 10.1089/acm.2018.0141

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  18 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

2.  The physician and unorthodox cancer therapies. The American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1997-01       Impact factor: 44.544

3.  Medical reconciliation of dietary supplements: don't ask, don't tell.

Authors:  Paula Gardiner; Ekaterina Sadikova; Amanda C Filippelli; Laura F White; Brian W Jack
Journal:  Patient Educ Couns       Date:  2015-01-14

4.  What physicians can learn from consumers of dietary supplements.

Authors:  B C Eliason; J Huebner; L Marchand
Journal:  J Fam Pract       Date:  1999-06       Impact factor: 0.493

5.  Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.

Authors:  M A Richardson; T Sanders; J L Palmer; A Greisinger; S E Singletary
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

6.  Online survey of patients with breast cancer on complementary and alternative medicine.

Authors:  Jutta Huebner; Karsten Muenstedt; Franz J Prott; Christoph Stoll; Oliver Micke; Jens Buentzel; Ralph Muecke; Bianca Senf
Journal:  Breast Care (Basel)       Date:  2014-02       Impact factor: 2.860

7.  Herbal and dietary supplement disclosure to health care providers by individuals with chronic conditions.

Authors:  Darshan H Mehta; Paula M Gardiner; Russell S Phillips; Ellen P McCarthy
Journal:  J Altern Complement Med       Date:  2008-12       Impact factor: 2.579

8.  The use of complementary therapies by breast cancer patients attending conventional treatment.

Authors:  E Crocetti; N Crotti; A Feltrin; P Ponton; M Geddes; E Buiatti
Journal:  Eur J Cancer       Date:  1998-02       Impact factor: 9.162

9.  Gender differences in prevalence and associations for use of CAM in a large population study.

Authors:  Agnete E Kristoffersen; Trine Stub; Anita Salamonsen; Frauke Musial; Katarina Hamberg
Journal:  BMC Complement Altern Med       Date:  2014-12-03       Impact factor: 3.659

10.  Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use.

Authors:  Agnete E Kristoffersen; Arne J Norheim; Vinjar M Fønnebø
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-28       Impact factor: 2.629

View more
  4 in total

1.  Complementary and alternative medicine use in glioma patients in France.

Authors:  Emilie Le Rhun; Patrick Devos; Véronique Bourg; Amélie Darlix; Véronique Lorgis; Guido Ahle; Mathieu Boone; Luc Taillandier; Elsa Curtit; Louis Gras; Christine Lebrun Frenay; Dorothee Gramatzki; Carole Ramirez; Nicolas Simon; Michael Weller
Journal:  J Neurooncol       Date:  2019-10-21       Impact factor: 4.130

2.  A pre-post evaluation of oncology healthcare providers' knowledge, attitudes, and practices following the implementation of a complementary medicine practice guideline.

Authors:  Emilie N Hayward; Cody Z Watling; Lynda G Balneaves
Journal:  Support Care Cancer       Date:  2021-06-07       Impact factor: 3.603

Review 3.  Addressing Complementary and Alternative Medicine Use Among Individuals With Cancer: An Integrative Review and Clinical Practice Guideline.

Authors:  Lynda G Balneaves; Cody Z Watling; Emilie N Hayward; Brenda Ross; Jill Taylor-Brown; Antony Porcino; Tracy L O Truant
Journal:  J Natl Cancer Inst       Date:  2022-01-11       Impact factor: 13.506

4.  "Part of the Conversation": A Qualitative Study of Oncology Healthcare Professionals' Experiences of Integrating Standardized Assessment and Documentation of Complementary Medicine.

Authors:  Lynda G Balneaves; Cody Z Watling
Journal:  Integr Cancer Ther       Date:  2022 Jan-Dec       Impact factor: 3.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.